Page last updated: 2024-08-24

plerixafor and Edema

plerixafor has been researched along with Edema in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, R; Gaines, T; Liang, Z; Liu, S; Mooring, SR; Oum, Y; Shi, Q; Shim, H; Yoon, Y1
Bai, R; Feng, A; Han, Y; Liang, Z; Liu, S; Oum, Y; Shi, Q; Shim, H; Yoon, Y; Yun, CC1
Bai, R; Feng, A; Liang, Z; Oum, Y; Salgado, E; Shim, H; Sun, J; Xie, Y; Yoon, Y1
Liang, Z; Mooring, SR; Shim, H; Virani, S; Yoon, Y1

Other Studies

4 other study(ies) available for plerixafor and Edema

ArticleYear
Symmetrical bis-tertiary amines as novel CXCR4 inhibitors.
    European journal of medicinal chemistry, 2016, Aug-08, Volume: 118

    Topics: Amines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Design; Edema; Mice; Molecular Docking Simulation; Protein Conformation; Receptors, CXCR4; Structure-Activity Relationship

2016
Development of CXCR4 modulators by virtual HTS of a novel amide-sulfamide compound library.
    European journal of medicinal chemistry, 2017, Jan-27, Volume: 126

    Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokine CXCL12; Drug Design; Drug Evaluation, Preclinical; Edema; High-Throughput Screening Assays; Mice; Molecular Docking Simulation; Phosphorylation; Protein Conformation; Proto-Oncogene Proteins c-akt; Receptors, CXCR4; Tumor Necrosis Factor-alpha; User-Computer Interface

2017
Anti-inflammatory hybrids of secondary amines and amide-sulfamide derivatives.
    European journal of medicinal chemistry, 2018, Apr-25, Volume: 150

    Topics: Amides; Amines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemokine CXCL12; Dose-Response Relationship, Drug; Ear; Edema; Humans; Inflammation; Mice; Mice, Nude; Molecular Structure; Receptors, CXCR4; Structure-Activity Relationship

2018
Synthesis and evaluation of 2,5-diamino and 2,5-dianilinomethyl pyridine analogues as potential CXCR4 antagonists.
    Bioorganic & medicinal chemistry letters, 2019, 01-15, Volume: 29, Issue:2

    Topics: Animals; Carrageenan; Dose-Response Relationship, Drug; Drug Design; Edema; Humans; Inflammation; Mice; Molecular Structure; Pyridines; Receptors, CXCR4; Structure-Activity Relationship

2019